Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNevi’a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: [email protected]

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    35,686

Stocks News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,570.4041.30-0.48%
CAC 407,910.4931.93-0.40%
DAX 4024,122.4086.290.36%
Dow JONES (US)41,860.44816.80-1.91%
FTSE 1008,786.465.340.06%
HKSE23,627.38200.40-0.84%
NASDAQ18,872.64270.07-1.41%
Nikkei 22537,026.98272.00-0.73%
NZX 50 Index12,662.2540.85-0.32%
S&P 5005,844.6195.85-1.61%
S&P/ASX 2008,348.7038.10-0.45%
SSE Composite Index3,383.084.49-0.13%

Market Movers